Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2026-06-03 17:36:50 ET · period of report 2026-06-02 · accession 0001193125-26-255834 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-03 17:36 | 2026-06-02+ | CRBP | Saxena Nishant C | Chief Business Off | P - Purchase | $7.50 | +13.5K | 75.3K | +22% | +$101.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2026-06-02 | P | A | 4,500 | $7.33 | 66,300 | D | — | — | (F1) The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.33 to $7.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule as previously reported. |
| 2 | Common | Common Stock, par value $0.0001 per share | 2026-06-03 | P | A | 9,000 | $7.58 | 75,300 | D | — | — | (F2) This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule as previously reported. |